Echo Therapeutics, Inc. Derivative, Loss on Derivative
Echo Therapeutics, Inc. reported Derivative, Loss on Derivative of $70.00 thousand for the 3-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Notes › Derivative Instruments and Hedging Activities
us-gaap:DerivativeLossOnDerivative · last filed 2013-11-07
- Echo Therapeutics, Inc. derivative, loss on derivative for the quarter ending 2013-09-30 was $70.00K, a 82.50% decline year-over-year.
- Echo Therapeutics, Inc. derivative, loss on derivative for the quarter ending 2012-09-30 was $400.00K.
- Echo Therapeutics, Inc. derivative, loss on derivative for the quarter ending 2012-06-30 was $42.00K, a 65.57% decline year-over-year.
- Echo Therapeutics, Inc. derivative, loss on derivative for the quarter ending 2012-03-31 was $2.26M.
- Echo Therapeutics, Inc. derivative, loss on derivative for fiscal 2011 was -$1.76M.
| Period end | Derivative, Loss on Derivative 3 month | Derivative, Loss on Derivative 6 month | Derivative, Loss on Derivative 9 month | Derivative, Loss on Derivative 12 month |
|---|---|---|---|---|
| 2013-09-30 | $70.00K 10-Q · filed 2013-11-07 | |||
| 2012-09-30 | $400.00K 10-Q · filed 2012-11-08 | $442.00K derived: sum of 2 quarters · filed 2013-08-09 | $2.70M derived: sum of 3 quarters · filed 2013-08-09 | -$1.32M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-06-30 | $42.00K 10-Q · filed 2013-08-09 | $2.30M derived: sum of 2 quarters · filed 2013-08-09 | -$1.72M derived: sum of 3 quarters · filed 2013-08-09 | -$2.61M derived: sum of 4 quarters · filed 2013-08-09 |
| 2012-03-31 | $2.26M 10-Q · filed 2013-05-10 | -$1.76M derived: sum of 2 quarters · filed 2013-05-10 | -$2.66M derived: sum of 3 quarters · filed 2013-05-10 | -$2.53M derived: sum of 4 quarters · filed 2013-05-10 |
| 2011-12-31 | -$4.02M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | -$4.92M derived: sum of 2 quarters · filed 2013-03-18 | -$4.79M derived: sum of 3 quarters · filed 2013-03-18 | -$1.76M 10-K · filed 2013-03-18 |
| 2011-09-30 | -$893.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | -$771.00K derived: sum of 2 quarters · filed 2012-11-08 | $2.26M 10-Q · filed 2012-11-08 | |
| 2011-06-30 | $122.00K 10-Q · filed 2012-08-09 | $3.15M 10-Q · filed 2012-08-09 |